Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 6, 2024
BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in fireside chats at two upcoming investor conferences:
Read more at globenewswire.com
